BURZYNSKI RESEARCH INSTITUTE INC
CIK 724445fmd_1F9H4XTDATMEZ5XKXBQ22CASWPManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Mar 01, 2010 to Nov 30, 2025, 62 periods
0 filings
From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).
Loading